Human uterine and ovarian expression of growth hormone-releasing hormone messenger RNA in benign and malignant gynecologic conditions

被引:41
|
作者
Khorram, O [1 ]
Garthwaite, M [1 ]
Grosen, E [1 ]
Golos, T [1 ]
机构
[1] Univ Wisconsin, Dept Obstet & Gynecol, Madison, WI 53706 USA
关键词
growth hormone-releasing hormone; endometrium; ovary; endometriosis; endometrial cancer; ovarian cancer;
D O I
10.1016/S0015-0282(00)01658-7
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To determine uterine and ovarian expression of growth hormone-releasing hormone (GHRH) messenger RNA (mRNA) in benign and pathologic gynecologic states. Design: Case-control study. Setting: Tertiary-care academic department. Patient(s): Women undergoing hysterectomy for benign or malignant gynecologic conditions. Intervention(s): Ovarian and uterine tissue was obtained for measurement of GHRH mRNA levels by reverse transcription polymerase chain reaction. Main Outcome Measure(s): Levels of GHRH mRNA in normal tissues were compared with those in tissues with pathologic abnormalities. Result(s): Growth hormone-releasing hormone mRNA was detectable in the ovary, endometrium, myometrium, fallopian tubes, and placenta. Levels of GHRH mRNA were significantly increased in secretory endometrium compared with proliferative endometrium. Hormone replacement therapy did not affect endometrial GHRH mRNA levels. Uterine myomas expressed similar levels of GHRH mRNA as normal myometrium. No changes in endometrial GHRH mRNA were detected in endometrial cancers compared with normal endometrium or myometrium obtained from the same patient; however, these levels were higher than those in noncancerous myometrial tissue obtained from other patients with benign gynecologic disease. In ovarian tissue, no differences in GHRH mRNA were found between premenopausal and postmenopausal women. Ovarian GHRH mRNA was significantly decreased in endometriotic cysts, whereas significantly greater GHRH expression occurred in ovarian cancer compared with normal ovarian tissue. Conclusion(s): Endometrial and ovarian GHRH gene transcription are altered in selective physiologic and pathologic states and are influenced by such factors as ovarian hormones, Because it is a growth factor, GHRH may promote endometrial proliferation and may be involved in the pathogenesis of ovarian and endometrial cancer and endometriosis. (C) 2001 by American Society for Reproductive Medicine.
引用
收藏
页码:174 / 179
页数:6
相关论文
共 50 条
  • [1] Growth Hormone-Releasing Hormone Antagonists Inhibit Growth of Human Ovarian Cancer
    Papadia, A.
    Schally, A. V.
    Halmos, G.
    Varga, J. L.
    Seitz, S.
    Buchholz, S.
    Rick, F.
    Zarandi, M.
    Bellyei, S.
    Treszl, A.
    Szalontay, L.
    Lucci, J. A.
    HORMONE AND METABOLIC RESEARCH, 2011, 43 (11) : 816 - 820
  • [2] Novel antagonists of growth hormone-releasing hormone inhibit growth and vascularization of human experimental ovarian cancers
    Klukovits, Anna
    Schally, Andrew V.
    Szalontay, Luca
    Vidaurre, Irving
    Papadia, Andrea
    Zarandi, Marta
    Varga, Jozsef L.
    Block, Norman L.
    Halmos, Gabor
    CANCER, 2012, 118 (03) : 670 - 680
  • [3] Sleep deprivation increases somatostatin and growth hormone-releasing hormone messenger RNA in the rat hypothalamus
    Toppila, J
    Alanko, L
    Asikainen, M
    Tobler, I
    Stenberg, D
    PorkkaHeiskanen, T
    JOURNAL OF SLEEP RESEARCH, 1997, 6 (03) : 171 - 178
  • [4] Expression of receptors for luteinizing hormone-releasing hormone in human ovarian and endometrial cancers:: Frequency, autoregulation, and correlation with direct antiproliferative activity of luteinizing hormone-releasing hormone analogues
    Völker, P
    Gründker, C
    Schmidt, O
    Schulz, KD
    Emons, G
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2002, 186 (02) : 171 - 179
  • [5] Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma
    Villanova, Tania
    Gesmundo, Iacopo
    Audrito, Valentina
    Vitale, Nicoletta
    Silvagno, Francesca
    Musuraca, Chiara
    Righi, Luisella
    Libener, Roberta
    Riganti, Chiara
    Bironzo, Paolo
    Deaglio, Silvia
    Papotti, Mauro
    Cai, Renzhi
    Sha, Wei
    Ghigo, Ezio
    Schally, Andrew V.
    Granata, Riccarda
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (06) : 2226 - 2231
  • [6] Expression profiles of growth hormone-releasing hormone and growth hormone-releasing hormone receptor during chicken embryonic pituitary development
    Wang, CY
    Wang, Y
    Li, J
    Leung, FC
    POULTRY SCIENCE, 2006, 85 (03) : 569 - 576
  • [7] Combining Growth Hormone-Releasing Hormone Antagonist With Luteinizing Hormone-Releasing Hormone Antagonist Greatly Augments Benign Prostatic Hyperplasia Shrinkage
    Rick, Ferenc G.
    Szalontay, Luca
    Schally, Andrew V.
    Block, Norman L.
    Nadji, Mehrdad
    Szepeshazi, Karoly
    Vidaurre, Irving
    Zarandi, Marta
    Kovacs, Magdolna
    Rekasi, Zoltan
    JOURNAL OF UROLOGY, 2012, 187 (04) : 1498 - 1504
  • [8] IMMUNOHISTOCHEMICAL LOCALIZATION OF GROWTH HORMONE-RELEASING HORMONE IN HUMAN GONADS
    MORETTI, C
    FABBRI, A
    GNESSI, L
    BONIFACIO, V
    BOLOTTI, M
    ARIZZI, M
    NAZZICONE, Q
    SPERA, G
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1990, 13 (04): : 301 - 305
  • [9] GROWTH HORMONE-RELEASING HORMONE AND SOMATOSTATIN IN NORMAL AND TUMORAL HUMAN PITUITARIES
    BENLOT, C
    PAGESY, P
    PEILLON, F
    JOUBERTBRESSION, D
    PEPTIDES, 1991, 12 (05) : 945 - 950
  • [10] Elevation of Growth Hormone-Releasing Hormone Receptor Messenger Ribonucleic Acid Expression in Growth Hormone-Secreting Pituitary Adenoma With Gsα Protein Mutation
    Sakai, Naoyuki
    Kim, Kyongsong
    Sanno, Naoko
    Yoshida, Daizo
    Teramoto, Akira
    Shibasaki, Tamotsu
    NEUROLOGIA MEDICO-CHIRURGICA, 2008, 48 (11) : 481 - 487